LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT DATED AS OF AUGUST 5, 2016 BY AND BETWEEN MEI PHARMA, INC. AND HELSINN HEALTHCARE SALicense, Development and Commercialization Agreement • November 9th, 2016 • MEI Pharma, Inc. • Pharmaceutical preparations • New York
THIS ASSET PURCHASE AGREEMENT is made as of August 7, 2012 by and between MEI Pharma, Inc., a Delaware corporation (“Purchaser”), and S*Bio Pte Ltd., a Singapore private limited company (“Seller”).
COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • November 9th, 2016 • MEI Pharma, Inc. • Pharmaceutical preparations • New York
THIS COMMON STOCK PURCHASE AGREEMENT (this “Agreement”) is entered into as of August 5, 2016, by and among MEl Pharma, Inc., a Delaware corporation (the “Company”), and Helsinn Investment Fund SA, a limited liability company organized under the laws of Luxembourg (“Purchaser”).
